NASDAQ · Biotechnology

GeoVax Labs Inc (GOVX)

$0.36 -6.81%

Add alert

22 Oversold Daily RSI (14) · 18 Sep 2026

Moving averages

SMA 200$2.40-85.13%

Company profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.

SectorHealthcare

IndustryBiotechnology

Market cap$4.21M

P/E ratioNone

EPS$-5.62

Beta3.654

Dividend yield0.00%

52-week high$17.78

52-week low$0.45

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 44 VRTX Vertex Pharmaceuticals Inc RSI 41 CRSP CRISPR Therapeutics AG RSI 55 IOVA Iovance Biotherapeutics Inc RSI 76 MRNA Moderna Inc RSI 63 VKTX Viking Therapeutics Inc RSI 31 SRPT Sarepta Therapeutics Inc RSI 50 EDIT Editas Medicine Inc RSI 43 NVAX Novavax Inc RSI 62 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 59

Free forever

RSI alerts for GOVX

Get an email the moment GeoVax Labs Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 6:54 AM EDT